Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
A Prospective, Single Arm, Longitudinal Cohort Study To Assess Biomarkers In Real World Patients With Severe Asthma
Sponsor: Hoffmann-La Roche
This PHASE4 trial investigates Asthma and is currently completed. Hoffmann-La Roche leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
May 2019 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 6 earlier versions
-
Jun 2018 — May 2019 [monthly]
Completed PHASE4
-
Apr 2018 — Jun 2018 [monthly]
Completed PHASE4
-
Aug 2017 — Apr 2018 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
May 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE4
-
Feb 2017 — May 2017 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .